Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Dividends payables (2016)

Historic Dividends payables for Altimmune (ALT) over the last 1 years, with Q4 2016 value amounting to $197.1 million.

  • Altimmune's Dividends payables changed N/A to $197.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $197.1 million, marking a year-over-year change of. This contributed to the annual value of $197.1 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Altimmune's Dividends payables stood at $197.1 million.
  • In the past 5 years, Altimmune's Dividends payables registered a high of $197.1 million during Q4 2016, and its lowest value of $197.1 million during Q4 2016.